California Stem Cell Agency Reviews Its Response to Blue Ribbon Recommendations for Major Changes
The outside counsel for the $3 billion California stem cell agency has revisited actions taken by the agency in the wake of the Institute of Medicine report that recommended sweeping changes to deal with conflicts of interest at the agency, its controversial dual executive arrangement and the fundamental nature of its governing board.
James Harrison of R…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.